Zomacton

DRUG3 trials

Sponsors

Ferring Pharmaceuticals

Conditions

Growth DisordersGrowth Hormone DeficiencyTurner's Syndrome

Phase 3

An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG

CompletedNCT00250250

Ferring PharmaceuticalsTurner's Syndrome

Start: 2005-10-31End: 2006-08-31Updated: 2011-05-20

A Study of Zomacton in Children With Growth Hormone Deficiency

CompletedNCT00884000

Ferring PharmaceuticalsGrowth Hormone Deficiency

Start: 2010-01-31End: 2012-07-31Updated: 2012-07-17

Unknown Phase

Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner Syndrome

TerminatedNCT03274973

Ferring PharmaceuticalsGrowth Disorders

Start: 2018-05-14End: 2018-10-31Updated: 2018-12-13